Guardant Health Stock Plan Amendment
Guardant Health granted performance-based restricted stock units (PSUs) to Co-CEOs Helmy Eltoukhy and AmirAli Talasaz under the 2018 Incentive Award Plan. Each executive received 465,413 PSUs at target, with vesting 100% tied to the company's total shareholder return (TSR) relative to the S&P 500 Index over three-year and five-year periods. The awards include a cap at 100% of target if absolute TSR is negative and require additional post-vesting holding periods.
- Term
- 5 years